SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 88 filers reported holding SYNAGEVA BIOPHARMA CORP in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $46,424,000 | -47.7% | 476 | -63.1% | 0.00% | – |
| Q3 2014 | $88,726,000 | +1222.9% | 1,290 | +1915.6% | 0.00% | – |
| Q2 2014 | $6,707,000 | -58.2% | 64 | -74.2% | 0.00% | – |
| Q4 2013 | $16,051,000 | -94.6% | 248 | -94.7% | 0.00% | – |
| Q3 2013 | $298,504,000 | +11.7% | 4,709 | -26.0% | 0.00% | – |
| Q2 2013 | $267,330,000 | – | 6,365 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|